|
Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.
|
21615592
|
Brain Pathol.
|
|
New promising drug targets in cancer- and metastasis-initiating cells.
|
20338259
|
Drug Discov. Today
|
|
Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity.
|
21393431
|
Am. J. Physiol. Gastrointest. Liver Physiol.
|
|
Role of mucins in the skin during benign and malignant conditions.
|
21146919
|
Cancer Lett.
|
|
Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility.
|
21347333
|
PLoS ONE
|
|
Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
|
21364589
|
Br. J. Cancer
|
|
Mucin-interacting proteins: from function to therapeutics.
|
19913432
|
Trends Biochem. Sci.
|
|
Current status of molecular markers for early detection of sporadic pancreatic cancer.
|
20888394
|
Biochim. Biophys. Acta
|
|
Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.
|
20179686
|
Am. J. Gastroenterol.
|
|
Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.
|
21059814
|
Clin. Cancer Res.
|
|
MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
|
20004512
|
Cancer Lett.
|
|
Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
|
20716670
|
Pharmacol. Rev.
|
|
MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.
|
20303649
|
Cancer Lett.
|
|
Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scattering.
|
21391573
|
Anal. Chem.
|
|
New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
|
20552555
|
Histol. Histopathol.
|
|
Current status of mucins in the diagnosis and therapy of cancer.
|
19904814
|
Biofactors
|
|
Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.
|
19725922
|
J. Cell. Mol. Med.
|
|
Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.
|
20578239
|
J. Cell. Physiol.
|
|
Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.
|
21277939
|
Biochim. Biophys. Acta
|
|
Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases.
|
20591909
|
J. Clin. Pathol.
|
|
MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.
|
20697346
|
Oncogene
|
|
DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.
|
20926598
|
Glycobiology
|
|
The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.
|
22513004
|
Biochim. Biophys. Acta
|
|
Recent trends in antibody-based oncologic imaging.
|
22104729
|
Cancer Lett.
|
|
Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer.
|
22820136
|
Cancer Biomark
|
|
Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapies.
|
20423995
|
Mol. Cancer Ther.
|
|
Novel therapies against aggressive and recurrent epithelial cancers by molecular targeting tumor- and metastasis-initiating cells and their progenies.
|
20184544
|
Anticancer Agents Med Chem
|
|
Discovering the route from inflammation to pancreatic cancer.
|
23207606
|
Minerva Gastroenterol Dietol
|
|
Early diagnosis of pancreatic cancer: challenges and new developments.
|
23075238
|
Biomark Med
|
|
Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
|
22614008
|
Oncogene
|
|
Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy.
|
23102107
|
J Hematol Oncol
|
|
Overexpression of ecdysoneless in pancreatic cancer and its role in oncogenesis by regulating glycolysis.
|
22977192
|
Clin. Cancer Res.
|
|
MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
|
23152882
|
PLoS ONE
|
|
Holy Basil leaf extract decreases tumorigenicity and metastasis of aggressive human pancreatic cancer cells in vitro and in vivo: potential role in therapy.
|
23523869
|
Cancer Lett.
|
|
Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer.
|
22970168
|
PLoS ONE
|
|
Emerging trends for radioimmunotherapy in solid tumors.
|
23844555
|
Cancer Biother. Radiopharm.
|
|
Nano-immunoassay with improved performance for detection of cancer biomarkers.
|
25200613
|
Nanomedicine
|
|
Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies.
|
22457110
|
Adv. Exp. Med. Biol.
|
|
Quantitative real-time PCR expression analysis of peripheral blood mononuclear cells in pancreatic cancer patients.
|
23359153
|
Methods Mol. Biol.
|
|
Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.
|
23921963
|
Pancreas
|
|
Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.
|
23383312
|
PLoS ONE
|
|
Immunohistochemistry of pancreatic neoplasia.
|
23359148
|
Methods Mol. Biol.
|
|
Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling.
|
23920124
|
Cancer Lett.
|
|
Interplay between smoking-induced genotoxicity and altered signaling in pancreatic carcinogenesis.
|
22623649
|
Carcinogenesis
|
|
Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.
|
22442756
|
World J Clin Oncol
|
|
Analysis of tumor-associated mucin glycotopes by Western transfer methods.
|
23359164
|
Methods Mol. Biol.
|
|
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.
|
23301832
|
J. Cell. Mol. Med.
|
|
Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism.
|
22475682
|
Cancer Lett.
|
|
Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas.
|
23146921
|
Pancreas
|
|
Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.
|
22903142
|
Drug Discov. Today
|
|
Mucins in pancreatic cancer and its microenvironment.
|
23856888
|
Nat Rev Gastroenterol Hepatol
|
|
Prospects of miRNA-based therapy for pancreatic cancer.
|
23834151
|
Curr Drug Targets
|
|
Targeting the EGFR signaling pathway in cancer therapy.
|
22239438
|
Expert Opin. Ther. Targets
|
|
Incidence and prognostic significance of second primary cancers in renal cell carcinoma.
|
22441339
|
Am. J. Clin. Oncol.
|
|
Mucins and toll-like receptors: kith and kin in infection and cancer.
|
22306702
|
Cancer Lett.
|
|
MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.
|
21785467
|
Oncogene
|
|
Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab.
|
21691572
|
Case Rep Oncol
|
|
Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells.
|
22105367
|
Oncogene
|
|
Expression of intestinal MUC17 membrane-bound mucin in inflammatory and neoplastic diseases of the colon.
|
20702471
|
J. Clin. Pathol.
|
|
Lung cancer in women: role of estrogens.
|
20658912
|
Expert Rev Respir Med
|
|
Human RNA polymerase II-association factor 1 (hPaf1/PD2) regulates histone methylation and chromatin remodeling in pancreatic cancer.
|
22046413
|
PLoS ONE
|
|
Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.
|
21886786
|
PLoS ONE
|
|
Marital status and survival in pancreatic cancer patients: a SEER based analysis.
|
21698253
|
PLoS ONE
|
|
Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications.
|
19114129
|
Ageing Res. Rev.
|
|
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.
|
20348949
|
Oncogene
|
|
Mucin-based targeted pancreatic cancer therapy.
|
22372499
|
Curr. Pharm. Des.
|
|
Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
|
24278292
|
PLoS ONE
|
|
Antibody labeling with radioiodine and radiometals.
|
24567137
|
Methods Mol. Biol.
|
|
Aging of tissue-resident adult stem/progenitor cells and their pathological consequences.
|
19776709
|
Panminerva Med
|
|
Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy.
|
21859497
|
Chin Med
|
|
Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.
|
24273063
|
Cancer Epidemiol. Biomarkers Prev.
|
|
Smoking and microRNA dysregulation: a cancerous combination.
|
24238736
|
Trends Mol Med
|
|
Emerging role of mucins in epithelial to mesenchymal transition.
|
24168188
|
Curr Cancer Drug Targets
|
